NASDAQ: REGNRegeneron Pharmaceuticals Inc Stock Forecast, Predictions & Price Target
Analyst price target for REGN
Based on 16 analysts offering 12 month price targets for Regeneron Pharmaceuticals Inc.
Min Forecast
$720.00-19.46%
Avg Forecast
$1,002.63+12.15%
Max Forecast
$1,189.00+33%
Should I buy or sell REGN stock?
Based on 16 analysts offering ratings for Regeneron Pharmaceuticals Inc.
Buy
Strong Buy
6 analysts 37.5%
Buy
6 analysts 37.5%
Hold
3 analysts 18.75%
Sell
1 analysts 6.25%
Strong Sell
0 analysts 0%
Be the first to know when Wall Street analysts revise their REGN stock forecasts and price targets.
REGN stock forecasts by analyst
| Analyst / Firm | Rating | Action | Price Target | Upside/Downside | Date | Analyst Color |
|---|---|---|---|---|---|---|
| locked | locked | $00.00 | +00.00% | 2024-04-17 | ||
| locked | locked | $00.00 | +00.00% | 2024-04-17 | ||
| locked | locked | $00.00 | +00.00% | 2024-04-15 | ||
| locked | locked | $00.00 | +00.00% | 2024-04-12 | ||
| locked | locked | $00.00 | +00.00% | 2024-04-09 | ||
| Strong Buy | Maintains | $1,135.00 | +26.96% | 2024-04-03 | ||
| Strong Buy | Maintains | $1,115.00 | +24.72% | 2024-03-13 | ||
| Buy | Initiates Coverage On | $1,125.00 | +25.84% | 2024-03-12 | ||
| Buy | Initiates Coverage On | $1,125.00 | +25.84% | 2024-03-11 | ||
| Buy | Maintains | $1,082.00 | +21.03% | 2024-02-05 |
Forecast return on equity
Is REGN forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.66%
Forecast return on assets
Is REGN forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A
REGN revenue forecast
What is REGN's revenue in the next 3 years based on estimates from 9 analysts?
Avg 1 year Forecast
$14.0B+6.83%
Avg 2 year Forecast
$15.1B+15.12%
Avg 3 year Forecast
$16.2B+23.73%
REGN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast
REGN earnings growth forecast
How is REGN forecast to perform vs Biotechnology companies and vs the US market?
Company
4.84%
Industry
7.33%
Market
21.73%
REGN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
REGN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
REGN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast
REGN revenue growth forecast
How is REGN forecast to perform vs Biotechnology companies and vs the US market?
Company
7.34%
Industry
37.96%
Market
10.23%
REGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
REGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast
REGN vs Biotech Stocks
Regeneron Pharmaceuticals Stock Forecast FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.